Reliable response times. Smooth, efficient workflows. High quality diagnostics. Every time.

Inify Laboratories is a fully digital histopathology laboratory. We provide AI-powered diagnostic services within selected cancer types, starting with prostate biopsies in early 2023.
By combining state-of-the art AI, lab equipment with strict process control and a passionate cross-functional team, we aim to radically improve cancer diagnostics. The promise to our clients and partners includes reliable response times, high and consistent quality and more efficient workflows.

Get to know
us better!

Laboratory services to match challenging needs

1

Uncompromising quality

The road to the optimal pathology image begins with the biopsy procedure, where we work together with our customers to ensure samples are managed carefully from the start. Once the specimen has arrived at our lab facility, it is prepared for diagnosis using cutting-edge equipment, operated by our experienced, skilled and quality-focused biomedical scientists. All steps – grossing, embedding, dehydration, cutting, staining and scanning – are continuously calibrated and quality assured. From start to finish, you can trust that we leave nothing to chance.
2

Fast, impressively accurate AI

In 2020 our AI solution INIFY Prostate® was CE marked and it has a proven track record of both sensitivity (finding cancer) as well as specificity (identifying non-cancerous areas). This state-of-the-art AI is the heart of our tailor-made decision support tool, meticulously developed to provide a maximally efficient workflow. By managing all samples in a strictly streamlined and standardized way, we can continuously feed our AI with consistent, quality-controlled images. In this way we can provide accurate predictions, and at the same time work together with our pathologists to further fine-tune diagnosis quality and efficiency.

Our decision support tool has been evaluated in several clinical studies, with excellent results.
Read more about them here: 

In the Pan-European multicenter clinical study FirstPath, INIFY Prostate produced highly accurate, robust and homogenous results at all sites

• 
INIFY Prostate® shown to accurately outline suspicious prostate cancer in study with two prominent medical centers

Deep neural network as a decision support tool for the detection
of lymph node metastases of colorectal cancer
 (PDF)
3

Embedded sustainability

Our lab is constructed in close collaboration between our biomedical scientists and experts from the process development sector. This has led to a number of clever solutions for minimizing environmental impact. For example, we have a separate drain for collecting dangerous chemicals such as formalin and xylene, where the latter can even be recycled. Inify Laboratories aims to save energy in every step of our process. This is why our ventilated benches are only active when needed. We also do our best to keep our transports to a minimum, using eco-friendly options.
4

A solid foundation

Inify Laboratories is a spin off from ContextVision, a pioneer in algorithm development for medical image enhancement since 1983. Today, ContextVision’s state-of-the-art solutions for medical imaging are used in over 300,000 systems worldwide. Innovation, technical know-how and professionalism – have been the cornerstones of ContextVision’s enduring market leadership for the last 30 years – and Inify Laboratories is proud to continue on along this path. Our research foundation is strong, and our close collaboration with clinicians helps us ensure that technological breakthroughs truly benefit patients.

More about ContextVision

Learn more about what Inify Laboratories can do for you!

>